These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 29632619

  • 1. KAT3B-p300 and H3AcK18/H3AcK14 levels are prognostic markers for kidney ccRCC tumor aggressiveness and target of KAT inhibitor CPTH2.
    Cocco E, Leo M, Canzonetta C, Di Vito S, Mai A, Rotili D, Di Napoli A, Vecchione A, De Nunzio C, Filetici P, Stoppacciaro A.
    Clin Epigenetics; 2018; 10():44. PubMed ID: 29632619
    [Abstract] [Full Text] [Related]

  • 2. Lysophosphatidylcholine acyltransferase 1 upregulation and concomitant phospholipid alterations in clear cell renal cell carcinoma.
    Du Y, Wang Q, Zhang X, Wang X, Qin C, Sheng Z, Yin H, Jiang C, Li J, Xu T.
    J Exp Clin Cancer Res; 2017 May 12; 36(1):66. PubMed ID: 28494778
    [Abstract] [Full Text] [Related]

  • 3. The two glycolytic markers GLUT1 and MCT1 correlate with tumor grade and survival in clear-cell renal cell carcinoma.
    Ambrosetti D, Dufies M, Dadone B, Durand M, Borchiellini D, Amiel J, Pouyssegur J, Rioux-Leclercq N, Pages G, Burel-Vandenbos F, Mazure NM.
    PLoS One; 2018 May 12; 13(2):e0193477. PubMed ID: 29481555
    [Abstract] [Full Text] [Related]

  • 4. High-level S100A6 promotes metastasis and predicts the outcome of T1-T2 stage in clear cell renal cell carcinoma.
    Lyu X, Li H, Ma X, Li X, Gao Y, Ni D, Shen D, Gu L, Wang B, Zhang Y, Zhang X.
    Cell Biochem Biophys; 2015 Jan 12; 71(1):279-90. PubMed ID: 25120023
    [Abstract] [Full Text] [Related]

  • 5. NSD1 Inactivation and SETD2 Mutation Drive a Convergence toward Loss of Function of H3K36 Writers in Clear Cell Renal Cell Carcinomas.
    Su X, Zhang J, Mouawad R, Compérat E, Rouprêt M, Allanic F, Parra J, Bitker MO, Thompson EJ, Gowrishankar B, Houldsworth J, Weinstein JN, Tost J, Broom BM, Khayat D, Spano JP, Tannir NM, Malouf GG.
    Cancer Res; 2017 Sep 15; 77(18):4835-4845. PubMed ID: 28754676
    [Abstract] [Full Text] [Related]

  • 6. Overexpression of placenta specific 8 is associated with malignant progression and poor prognosis of clear cell renal cell carcinoma.
    Shi L, Xiao L, Heng B, Mo S, Chen W, Su Z.
    Int Urol Nephrol; 2017 Jul 15; 49(7):1165-1176. PubMed ID: 28349447
    [Abstract] [Full Text] [Related]

  • 7. Expression and Prognostic Significance of EP300, TP53 and BAX in Clear Cell Renal Cell Carcinoma.
    Godlewski J, Krazinski BE, Kowalczyk AE, Kiewisz J, Kiezun J, Kwiatkowski P, Sliwińska-Jewsiewicka A, Wierzbicki PW, Kmieć Z.
    Anticancer Res; 2017 Jun 15; 37(6):2927-2937. PubMed ID: 28551630
    [Abstract] [Full Text] [Related]

  • 8. An increase in long non-coding RNA PANDAR is associated with poor prognosis in clear cell renal cell carcinoma.
    Xu Y, Tong Y, Zhu J, Lei Z, Wan L, Zhu X, Ye F, Xie L.
    BMC Cancer; 2017 May 25; 17(1):373. PubMed ID: 28545465
    [Abstract] [Full Text] [Related]

  • 9. Up-regulation of miR-181a in clear cell renal cell carcinoma is associated with lower KLF6 expression, enhanced cell proliferation, accelerated cell cycle transition, and diminished apoptosis.
    Lei Z, Ma X, Li H, Zhang Y, Gao Y, Fan Y, Li X, Chen L, Xie Y, Chen J, Wu S, Tang L, Zhang X.
    Urol Oncol; 2018 Mar 25; 36(3):93.e23-93.e37. PubMed ID: 29066014
    [Abstract] [Full Text] [Related]

  • 10. Down-regulation of CD74 inhibits growth and invasion in clear cell renal cell carcinoma through HIF-1α pathway.
    Ji SQ, Su XL, Cheng WL, Zhang HJ, Zhao YQ, Han ZX.
    Urol Oncol; 2014 Feb 25; 32(2):153-61. PubMed ID: 23273913
    [Abstract] [Full Text] [Related]

  • 11. Histology-guided proteomic analysis to investigate the molecular profiles of clear cell Renal Cell Carcinoma grades.
    Stella M, Chinello C, Cazzaniga A, Smith A, Galli M, Piga I, Grasso A, Grasso M, Del Puppo M, Varallo M, Bovo G, Magni F.
    J Proteomics; 2019 Jan 16; 191():38-47. PubMed ID: 29698802
    [Abstract] [Full Text] [Related]

  • 12. Reduced expression of growth and differentiation factor-9 (GDF9) is associated with aggressive behaviour of human clear-cell renal cell carcinoma and poor patient survival.
    Du P, Ye L, Yang Y, Jiang WG.
    Anticancer Res; 2014 Nov 16; 34(11):6515-20. PubMed ID: 25368253
    [Abstract] [Full Text] [Related]

  • 13. High TXNDC5 expression predicts poor prognosis in renal cell carcinoma.
    Mo R, Peng J, Xiao J, Ma J, Li W, Wang J, Ruan Y, Ma S, Hong Y, Wang C, Gao K, Fan J.
    Tumour Biol; 2016 Jul 16; 37(7):9797-806. PubMed ID: 26810069
    [Abstract] [Full Text] [Related]

  • 14. CLEC3B is downregulated and inhibits proliferation in clear cell renal cell carcinoma.
    Liu J, Liu Z, Liu Q, Li L, Fan X, Wen T, An G.
    Oncol Rep; 2018 Oct 16; 40(4):2023-2035. PubMed ID: 30066941
    [Abstract] [Full Text] [Related]

  • 15. ΑB-crystallin in clear cell renal cell carcinoma: tumor progression and prognostic significance.
    Ho PY, Chueh SC, Chiou SH, Wang SM, Lin WC, Lee IL, Yang HY, Peng HC, Lai MK.
    Urol Oncol; 2013 Oct 16; 31(7):1367-77. PubMed ID: 22417627
    [Abstract] [Full Text] [Related]

  • 16. Decreased expression of long non-coding RNA NBAT-1 is associated with poor prognosis in patients with clear cell renal cell carcinoma.
    Xue S, Li QW, Che JP, Guo Y, Yang FQ, Zheng JH.
    Int J Clin Exp Pathol; 2015 Oct 16; 8(4):3765-74. PubMed ID: 26097558
    [Abstract] [Full Text] [Related]

  • 17. RhoB Acts as a Tumor Suppressor That Inhibits Malignancy of Clear Cell Renal Cell Carcinoma.
    Chen W, Niu S, Ma X, Zhang P, Gao Y, Fan Y, Pang H, Gong H, Shen D, Gu L, Zhang Y, Zhang X.
    PLoS One; 2016 Oct 16; 11(7):e0157599. PubMed ID: 27384222
    [Abstract] [Full Text] [Related]

  • 18. Cytoplasmic expression of Twist1, an EMT-related transcription factor, is associated with higher grades renal cell carcinomas and worse progression-free survival in clear cell renal cell carcinoma.
    Rasti A, Madjd Z, Abolhasani M, Mehrazma M, Janani L, Saeednejad Zanjani L, Asgari M.
    Clin Exp Med; 2018 May 16; 18(2):177-190. PubMed ID: 29204790
    [Abstract] [Full Text] [Related]

  • 19. Orai1 Expression Is Closely Related with Favorable Prognostic Factors in Clear Cell Renal Cell Carcinoma.
    Lkhagvadorj S, Kim JH, Oh SS, Lee MR, Jung JH, Chung HC, Cha SK, Eom M.
    J Korean Med Sci; 2016 Jun 16; 31(6):879-85. PubMed ID: 27247496
    [Abstract] [Full Text] [Related]

  • 20. Metabolic Modulation of Clear-cell Renal Cell Carcinoma with Dichloroacetate, an Inhibitor of Pyruvate Dehydrogenase Kinase.
    Kinnaird A, Dromparis P, Saleme B, Gurtu V, Watson K, Paulin R, Zervopoulos S, Stenson T, Sutendra G, Pink DB, Carmine-Simmen K, Moore R, Lewis JD, Michelakis ED.
    Eur Urol; 2016 Apr 16; 69(4):734-744. PubMed ID: 26433571
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.